• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Financial Services·SGSN.SW
Share

SGS S.A. Stocks

CHF 91.02Last Updated 04.09.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

CHF 22.23B

CHF 91.02
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in Geneva, Switzerland, in 1878, SGS SA is a prominent global provider specializing in inspection, verification, testing, certification, and quality assurance services. Its extensive operations reach across Europe, Africa, the Middle East, the Americas, and the Asia Pacific, structured into five main divisions: Connectivity & Products, Health & Nutrition, Industries & Environment, Natural Resources, and Knowledge. The company offers a comprehensive suite of services, including laboratory analysis, product scrutiny, consulting, process evaluation, and technical assistance. SGS also delivers cutting-edge digital solutions, such as cybersecurity, Internet of Things integration, digital platforms, and mobile applications. It provides specialized testing, inspection, and certification for critical industries like crop science, food, health science, and cosmetics, complemented by field services, technical assessments, and advisory expertise. Furthermore, SGS addresses industrial, public health, safety, and environmental testing requirements, often fulfilling public mandates. Its additional offerings span certification, training programs, supply chain integrity assurance, technical consulting, and ESG assurance services. The company also handles laboratory outsourcing, commodities logistics, geochemistry, metallurgy, sustainability initiatives, and market intelligence. SGS's diverse clientele includes sectors such as agriculture and food, chemicals, construction, consumer and retail, energy, industrial manufacturing, life sciences, mining, oil and gas, public institutions, and transportation.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, reasonably pr

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of SGSN.SW is 97.9 and suggests 7.51% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommenda

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

07.09.2026 14:56

OpenAI's new AI model pushed emerging market stocks to a two-month high

07.09.2026 14:10

Tyra shares are having their best day in 10 months. Investors are awaiting new data on its drug

07.09.2026 13:11

U.S. inflation, Apple's latest products, Oracle's earnings report: What Investors Need to Know This Week

07.09.2026 12:22

Brent surged to $98. U.S. officials said the nuclear deal with Iran might not go through

07.09.2026 10:53

Top Stories This Morning: The U.S. Has Left Open the Possibility of Withdrawing from the Iran Nuclear Deal; Anthropic Has Postponed Its IPO

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026